Pembrolizumab vs Tamoxifen
Pembrolizumab vs Tamoxifen: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Tamoxifen.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Tamoxifen: Selective estrogen receptor modulator (SERM).
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Tamoxifen — 5-7 days.
Chemical Properties
Molecular Formula: Tamoxifen — C26H29NO.
Molecular Weight: Tamoxifen — 371.5150 g/mol.
Type: Pembrolizumab — Antibody; Tamoxifen — Small molecule.